TrialBreast cancer research : BCR2017

Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.

Stephan Bernhardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.